Per edited: Bi Luming
According to the shenzhen medical insurance WeChat public account on the evening of February 10, 2021, in July 2021, the Shenzhen Municipal Medical Security Bureau verified and found that the staff of AstraZeneca Pharmaceutical Co., Ltd. was suspected of fraud and insurance fraud, and then under the guidance of the National Medical Insurance Bureau, jointly with the Shenzhen Municipal Public Security Bureau and other relevant units to investigate the case. After meticulous work, the case was successfully cracked, a fraud gang suspected of tampering with the genetic test results of tumor patients to defraud the medical insurance fund was smashed, 17 people involved in the case were arrested, and all criminal compulsory measures were taken in accordance with the law. At present, the case is under further investigation and handling.
It should be noted that at the end of January, the National Medical Insurance Bureau responded to the suspected fraud of medical insurance funds by the staff of AstraZeneca Pharmaceutical Co., Ltd. According to the News of the WeChat Public Account of the National Medical Insurance Bureau on January 29, in response to the situation that the staff of AstraZeneca Pharmaceutical Co., Ltd. was suspected of tampering with the genetic test results of tumor patients to defraud the medical insurance fund, the person in charge of the Fund Supervision Department of the National Medical Insurance Bureau said that in the early stage, according to the clues reported by the masses, the National Medical Insurance Bureau urged Shenzhen to set up a joint task force composed of medical insurance, public security, health and health, market supervision and other departments to conduct an in-depth investigation of the case, and all the criminal suspects have been arrested.
Recently, the National Medical Insurance Bureau and the Ministry of Public Security interviewed the relevant responsible persons of AstraZeneca China, reported the progress of the phased investigation of the case, required AstraZeneca China to strictly abide by laws and regulations, fully cooperate with relevant departments to do a good job in follow-up investigation, and immediately carry out internal investigation and rectification, plug marketing supervision loopholes, strengthen employee compliance education, effectively enhance the awareness of integrity, timely exposure of interviews and rectification. In accordance with the requirements of the interview, AstraZeneca China timely docked with the Shenzhen Municipal Medical Insurance Bureau and the Public Security Bureau to do a good job in the follow-up investigation of the case, urged employees to voluntarily surrender themselves with similar behavior, and announced the case and self-inspection and rectification on the official website of the enterprise.
In the next step, the National Medical Insurance Bureau will work with the Ministry of Public Security and the National Health Commission to carry out special rectification of the behavior of tampering with genetic test results to defraud the medical insurance fund nationwide, strike hard, comprehensively investigate, severely crack down on such fraudulent insurance fraud in accordance with laws and regulations, and resolutely protect the people's "medical treatment money" and "life-saving money". Here, it is also urged that relevant enterprises and personnel with similar behavior immediately surrender themselves to the local medical insurance department and public security department and strive for leniency.
Daily economic news